Cresset Asset Management, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Cresset Asset Management, LLC

  • $25.6 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$83.14 - $145.99 $357,917 - $628,486
-4,305 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$110.08 - $142.92 $86,632 - $112,478
-787 Reduced 15.46%
4,305 $511,000
Q4 2021

Feb 10, 2022
BUY
$99.73 - $148.48 $56,646 - $84,336
568 Added 12.56%
5,092 $702,000
Q3 2021

Nov 15, 2021
SELL
$98.85 - $138.91 $197 - $277
-2 Reduced 0.04%
4,524 $628,000
Q2 2021

Aug 10, 2021
BUY
$65.78 - $105.02 $297,720 - $475,320
4,526 New
4,526 $439,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.18B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email